CEACAM5 ANTIBODY-DRUG CONJUGATE FORMULATION

Provided are stabilized formulations of the human carcinoembryonic antigen-related cell adhesion molecule 5 (hCEACAM5)-targeted antibody-drug conjugate huMAb2-3-SPDB-DM4, as well as methods for making and using same. L'invention concerne des formulations stabilisées du conjugué anticorps-médica...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BONESTEBE, Audrey, LEMAN, Marie, HUILLE, Sylvain, AUTHELIN, Jean-René, BENSAID, Fethi, MANACHE-ALBERICI, Lucie
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BONESTEBE, Audrey
LEMAN, Marie
HUILLE, Sylvain
AUTHELIN, Jean-René
BENSAID, Fethi
MANACHE-ALBERICI, Lucie
description Provided are stabilized formulations of the human carcinoembryonic antigen-related cell adhesion molecule 5 (hCEACAM5)-targeted antibody-drug conjugate huMAb2-3-SPDB-DM4, as well as methods for making and using same. L'invention concerne des formulations stabilisées du conjugué anticorps-médicament ciblant la molécule d'adhésion cellulaire 5 liée à l'antigène carcinoembryonnaire humain (hCEACAM5), huMAb2-3-SPDB-DM4, ainsi que des procédés de production et d'utilisation de celui-ci.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022101165A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022101165A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022101165A13</originalsourceid><addsrcrecordid>eNrjZNB2dnV0dvQ1VXD0C_F08neJ1HUJCnVXcPb38wp1dwxxVXDzD_IN9XEM8fT342FgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGRoYGhoZmpo6GxsSpAgAAqCXC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CEACAM5 ANTIBODY-DRUG CONJUGATE FORMULATION</title><source>esp@cenet</source><creator>BONESTEBE, Audrey ; LEMAN, Marie ; HUILLE, Sylvain ; AUTHELIN, Jean-René ; BENSAID, Fethi ; MANACHE-ALBERICI, Lucie</creator><creatorcontrib>BONESTEBE, Audrey ; LEMAN, Marie ; HUILLE, Sylvain ; AUTHELIN, Jean-René ; BENSAID, Fethi ; MANACHE-ALBERICI, Lucie</creatorcontrib><description>Provided are stabilized formulations of the human carcinoembryonic antigen-related cell adhesion molecule 5 (hCEACAM5)-targeted antibody-drug conjugate huMAb2-3-SPDB-DM4, as well as methods for making and using same. L'invention concerne des formulations stabilisées du conjugué anticorps-médicament ciblant la molécule d'adhésion cellulaire 5 liée à l'antigène carcinoembryonnaire humain (hCEACAM5), huMAb2-3-SPDB-DM4, ainsi que des procédés de production et d'utilisation de celui-ci.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220519&amp;DB=EPODOC&amp;CC=WO&amp;NR=2022101165A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220519&amp;DB=EPODOC&amp;CC=WO&amp;NR=2022101165A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BONESTEBE, Audrey</creatorcontrib><creatorcontrib>LEMAN, Marie</creatorcontrib><creatorcontrib>HUILLE, Sylvain</creatorcontrib><creatorcontrib>AUTHELIN, Jean-René</creatorcontrib><creatorcontrib>BENSAID, Fethi</creatorcontrib><creatorcontrib>MANACHE-ALBERICI, Lucie</creatorcontrib><title>CEACAM5 ANTIBODY-DRUG CONJUGATE FORMULATION</title><description>Provided are stabilized formulations of the human carcinoembryonic antigen-related cell adhesion molecule 5 (hCEACAM5)-targeted antibody-drug conjugate huMAb2-3-SPDB-DM4, as well as methods for making and using same. L'invention concerne des formulations stabilisées du conjugué anticorps-médicament ciblant la molécule d'adhésion cellulaire 5 liée à l'antigène carcinoembryonnaire humain (hCEACAM5), huMAb2-3-SPDB-DM4, ainsi que des procédés de production et d'utilisation de celui-ci.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB2dnV0dvQ1VXD0C_F08neJ1HUJCnVXcPb38wp1dwxxVXDzD_IN9XEM8fT342FgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGRoYGhoZmpo6GxsSpAgAAqCXC</recordid><startdate>20220519</startdate><enddate>20220519</enddate><creator>BONESTEBE, Audrey</creator><creator>LEMAN, Marie</creator><creator>HUILLE, Sylvain</creator><creator>AUTHELIN, Jean-René</creator><creator>BENSAID, Fethi</creator><creator>MANACHE-ALBERICI, Lucie</creator><scope>EVB</scope></search><sort><creationdate>20220519</creationdate><title>CEACAM5 ANTIBODY-DRUG CONJUGATE FORMULATION</title><author>BONESTEBE, Audrey ; LEMAN, Marie ; HUILLE, Sylvain ; AUTHELIN, Jean-René ; BENSAID, Fethi ; MANACHE-ALBERICI, Lucie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022101165A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BONESTEBE, Audrey</creatorcontrib><creatorcontrib>LEMAN, Marie</creatorcontrib><creatorcontrib>HUILLE, Sylvain</creatorcontrib><creatorcontrib>AUTHELIN, Jean-René</creatorcontrib><creatorcontrib>BENSAID, Fethi</creatorcontrib><creatorcontrib>MANACHE-ALBERICI, Lucie</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BONESTEBE, Audrey</au><au>LEMAN, Marie</au><au>HUILLE, Sylvain</au><au>AUTHELIN, Jean-René</au><au>BENSAID, Fethi</au><au>MANACHE-ALBERICI, Lucie</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CEACAM5 ANTIBODY-DRUG CONJUGATE FORMULATION</title><date>2022-05-19</date><risdate>2022</risdate><abstract>Provided are stabilized formulations of the human carcinoembryonic antigen-related cell adhesion molecule 5 (hCEACAM5)-targeted antibody-drug conjugate huMAb2-3-SPDB-DM4, as well as methods for making and using same. L'invention concerne des formulations stabilisées du conjugué anticorps-médicament ciblant la molécule d'adhésion cellulaire 5 liée à l'antigène carcinoembryonnaire humain (hCEACAM5), huMAb2-3-SPDB-DM4, ainsi que des procédés de production et d'utilisation de celui-ci.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2022101165A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title CEACAM5 ANTIBODY-DRUG CONJUGATE FORMULATION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T22%3A00%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BONESTEBE,%20Audrey&rft.date=2022-05-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022101165A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true